Astera Labs, Inc. Common Stock growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +104.2%
EBITDA: +3719.3%
EBIT: +1126.7%
EPS: +554.3%
Free cash flow: +216.9%
Operating cash flow: +167.1%

Forward estimates

Revenue: +62.7%
EBITDA: —
EPS: +90.4%

Three-year CAGR

Revenue: +120.2%
EBITDA: +386.1%
EBIT: +249.4%
Net income: +362.7%
EPS: +306.3%
Free cash flow: +175.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.